|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Late last month, the Obama administration rolled out a five-point plan to combat drug-resistant bacteria, which it said causes 2 million infections and 23,000 deaths in the U.S. alone every year. A report ...
Mario Gabelli (Trades, Portfolio) is the founder of GAMCO Investors, a firm with $49.9 billion in assets under management across a range of funds.
In December, the FDA approved Zerbaxa, Cubist's antibiotic that combats urinary tract infections and intra-abdominal infections in adults around the world.